Related Experiment Video
Updated: Mar 10, 2026
09:43
Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
3.6K
Hydroxychloroquine in systemic lupus erythematosus (SLE).
1a Nephrological Unit , Humanitas Clinical and Research Center , Rozzano (Milano) , Italy.
Expert Opinion on Drug Safety
|December 9, 2016
Summary
Hydroxychloroquine (HCQ) is an effective and safe treatment for systemic lupus erythematosus (SLE), reducing flares and organ damage. It is also safe for pregnant women, though retinopathy risk requires monitoring.
Area of Science:
- Rheumatology
- Pharmacology
Background:
- Hydroxychloroquine (HCQ) is an alkalinizing drug that increases lysosomal pH, impacting cellular functions.
- HCQ is established as effective in managing autoimmune diseases like systemic lupus erythematosus (SLE).
Purpose of the Study:
- To review the mechanisms of action, efficacy, and safety of HCQ in SLE management.
- To evaluate HCQ's role in reducing disease activity, steroid dosage, organ damage, and thrombotic events.
Main Methods:
- Literature review of HCQ's use in systemic lupus erythematosus.
- Analysis of HCQ's pharmacological effects, clinical efficacy, and safety profile.
Main Results:
- HCQ can decrease SLE flares, enable lower steroid doses, and reduce organ damage.
- It may prevent thrombotic events associated with anti-phospholipid antibodies.
- HCQ is generally safe, suitable for pregnant women, but necessitates monitoring for retinopathy.
Conclusions:
- HCQ offers significant benefits for mild and severe SLE, including organ involvement and pregnancy.
- Its low cost and favorable safety profile support broader clinical application.
- Careful monitoring is essential to mitigate the risk of HCQ-induced retinopathy.
Related Concept Videos
01:26Nephrotic Syndrome II : Assessment and Medical Management
292
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
292
01:24Nephrotic Syndrome I : Introduction
796
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
796
01:15Antihypertensive Drugs: Thiazide-Class Diuretics
2.1K
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
2.1K
01:21Rheumatic Heart Disease III: Medical Management
445
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
445
01:24Nephrotic Syndrome III : Nursing Management
406
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
406
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
629
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
629